Syntekabio Inc (226330)

Currency in KRW
6,510
-180(-2.69%)
Closed·
226330 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
226330 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6,4906,740
52 wk Range
4,1959,430
Key Statistics
Bid/Ask
6,500.00 / 6,510.00
Prev. Close
6,690
Open
6,630
Day's Range
6,490-6,740
52 wk Range
4,195-9,430
Volume
53.28K
Average Volume (3m)
180.05K
1-Year Change
-13.77%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
226330 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Syntekabio Inc Company Profile

SyntekaBio, Inc. operates as an artificial intelligence new drug development company based on genomic big data primarily in South Korea. It derives new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology. The company also researches and develops biomarker detection for individual cancer drug screening, disease susceptibility, immune typing, pharmacogenomic typing, and multi-omics information-based drug side effect prediction technology. The company was founded in 2009 and is headquartered in Daejeon, South Korea.

Compare 226330 to Peers and Sector

Metrics to compare
226330
Peers
Sector
Relationship
P/E Ratio
−7.3x−2.0x−0.5x
PEG Ratio
0.190.310.00
Price/Book
5.6x1.9x2.6x
Price / LTM Sales
101.0x2.8x3.2x
Upside (Analyst Target)
-0.0%41.7%
Fair Value Upside
Unlock−0.8%6.1%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-478.00 / --
Revenue / Forecast
900.00M / --
EPS Revisions
Last 90 days

226330 Income Statement

FAQ

What Stock Exchange Does Syntekabio Trade On?

Syntekabio is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Syntekabio?

The stock symbol for Syntekabio is "226330."

What Is the Syntekabio Market Cap?

As of today, Syntekabio market cap is 99.33B.

What Is Syntekabio's Earnings Per Share (TTM)?

The Syntekabio EPS (TTM) is -886.84.

When Is the Next Syntekabio Earnings Date?

Syntekabio will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is 226330 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Syntekabio Stock Split?

Syntekabio has split 0 times.

How Many Employees Does Syntekabio Have?

Syntekabio has 0 employees.

What is the current trading status of Syntekabio (226330)?

As of 26 Jul 2025, Syntekabio (226330) is trading at a price of 6,510.00, with a previous close of 6,690.00. The stock has fluctuated within a day range of 6,490.00 to 6,740.00, while its 52-week range spans from 4,195.00 to 9,430.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.